AndHealth’s $57 Million Growth Financing

Kirkland & Ellis represented AndHealth in the transaction. AndHealth, a digital health company for reversing migraine and autoimmune diseases, closed its $57 million initial institutional financing, by leading technology investor...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Vitruvian Partners’ Acquisition of a Majority Ownership Stake in KCAS Bioanalytical and Biomarker Services

Kirkland & Ellis advised Vitruvian Partners on the deal. Vitruvian Partners, a leading international growth investor, completed its acquisition of a majority ownership stake in KCAS...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here